AAAAAA
Results: 1-25/32
Authors:
Lesage, P
Portenoy, RK
Citation: P. Lesage et Rk. Portenoy, Ethical challenges in the care of patients with serious illness, PAIN MED, 2(2), 2001, pp. 121-130
Authors:
Payne, R
Coluzzi, P
Hart, L
Simmonds, M
Lyss, A
Rauck, R
Berris, R
Busch, MA
Nordbrook, E
Loseth, DB
Portenoy, RK
Citation: R. Payne et al., Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain, J PAIN SYMP, 22(1), 2001, pp. 575-583
Authors:
Mercadante, S
Portenoy, RK
Citation: S. Mercadante et Rk. Portenoy, Opioid poorly-responsive cancer pain. Part 3. Clinical strategies lo improve opioid responsiveness, J PAIN SYMP, 21(4), 2001, pp. 338-354
Authors:
Mercadante, S
Portenoy, RK
Citation: S. Mercadante et Rk. Portenoy, Opioid poorly-responsive cancer pain. Part 2: Basic mechanisms that could shift dose response for analgesia, J PAIN SYMP, 21(3), 2001, pp. 255-264
Authors:
Mercadante, S
Portenoy, RK
Citation: S. Mercadante et Rk. Portenoy, Opioid poorly-responsive cancer pain. Part 1: Clinical considerations, J PAIN SYMP, 21(2), 2001, pp. 144-150
Authors:
Coluzzi, PH
Schwartzberg, L
Conroy, JD
Charapata, S
Gay, M
Busch, MA
Chavez, J
Ashley, J
Lebo, D
McCracken, M
Portenoy, RK
Citation: Ph. Coluzzi et al., Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC (R)) and morphine sulfate immediate release (MSIR (R)), PAIN, 91(1-2), 2001, pp. 123-130
Authors:
Cheville, A
Caraceni, A
Portenoy, RK
Citation: A. Cheville et al., Pain - Definition and assessment, REV PSYCH S, 19, 2000, pp. 1-22
Authors:
Caraceni, A
Cheville, A
Portenoy, RK
Citation: A. Caraceni et al., Pain management - Pharmacological and nonpharmacological treatments, REV PSYCH S, 19, 2000, pp. 23-88
Authors:
Portenoy, RK
Citation: Rk. Portenoy, Sedation in the imminently dying patient - The Wein article reviewed, ONCOLOGY-NY, 14(4), 2000, pp. 592
Authors:
Kim, KS
Glajchen, M
Portenoy, RK
Citation: Ks. Kim et al., Unwillingness to fill opioid analgesic prescriptions by local pharmacies, J PAIN SYMP, 20(3), 2000, pp. 160-162
Authors:
Portenoy, RK
Hassenbusch, SJ
Citation: Rk. Portenoy et Sj. Hassenbusch, PolyAnalgesic Consensus Conference 2000, J PAIN SYMP, 20(2), 2000, pp. S3-S3
Authors:
Hassenbusch, SJ
Portenoy, RK
Citation: Sj. Hassenbusch et Rk. Portenoy, Current practices in intraspinal therapy - A survey of clinical trends anddecision making, J PAIN SYMP, 20(2), 2000, pp. S4-S11
Authors:
Bennett, G
Serafini, M
Burchiel, K
Buchser, E
Classen, A
Deer, T
Du Pen, S
Ferrante, FM
Hassenbusch, SJ
Lou, L
Maeyaert, J
Penn, R
Portenoy, RK
Rauck, R
Willis, KD
Yaksh, T
Citation: G. Bennett et al., Evidence-based review of the literature on intrathecal delivery of pain medication, J PAIN SYMP, 20(2), 2000, pp. S12-S36
Authors:
Bennett, G
Burchiel, K
Buchser, E
Classen, A
Deer, T
Du Pen, S
Ferrante, FM
Hassenbusch, SJ
Lou, L
Maeyaert, J
Penn, R
Portenoy, RK
Rauck, R
Serafini, M
Willis, KD
Yaksh, T
Citation: G. Bennett et al., Clinical guidelines for intraspinal infusion: Report of an expert panel, J PAIN SYMP, 20(2), 2000, pp. S37-S43
Authors:
Collins, JJ
Byrnes, ME
Dunkel, IJ
Lapin, J
Nadel, T
Thaler, HT
Polyak, T
Rapkin, B
Portenoy, RK
Citation: Jj. Collins et al., The measurement of symptoms in children with cancer, J PAIN SYMP, 19(5), 2000, pp. 363-377
Authors:
Passik, SD
Kirsh, KL
McDonald, MV
Ahn, S
Russak, SM
Martin, L
Rosenfeld, B
Breitbart, WS
Portenoy, RK
Citation: Sd. Passik et al., A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients, J PAIN SYMP, 19(4), 2000, pp. 274-286
Authors:
Portenoy, RK
Citation: Rk. Portenoy, Introduction - Evolving role of NMDA-receptor antagonists in analgesia, J PAIN SYMP, 19(1), 2000, pp. S1-S1
Authors:
Portenoy, RK
Citation: Rk. Portenoy, Current pharmacotherapy of chronic pain, J PAIN SYMP, 19(1), 2000, pp. S16-S20
Authors:
Portenoy, RK
Price, DD
Bennett, GJ
Payne, R
Katz, NP",Weinstein,Marcus,Furst,Keiser,Caruso,Sang,Zukovsky
Citation: Rk. Portenoy et al., Enhancing opioid analgesia with NMDA-receptor antagonists: Clarifying the clinical importance - A roundtable discussion, J PAIN SYMP, 19(1), 2000, pp. S57-S64
Authors:
Passik, SD
Schreiber, J
Kirsh, KL
Portenoy, RK
Citation: Sd. Passik et al., A chart review of the ordering and documentation of urine toxicology screens in a cancer center: Do they influence patient management?, J PAIN SYMP, 19(1), 2000, pp. 40-44
Authors:
Farrar, JT
Portenoy, RK
Berlin, JA
Kinman, JL
Strom, BL
Citation: Jt. Farrar et al., Defining the clinically important difference in pain outcome measures, PAIN, 88(3), 2000, pp. 287-294
Authors:
Sulmasy, DP
Ury, WA
Ahronheim, JC
Siegler, M
Kass, L
Lantos, J
Burt, RA
Foley, K
Payne, R
Gomez, C
Krizek, TJ
Pellegrino, ED
Portenoy, RK
Citation: Dp. Sulmasy et al., Responding to intractable terminal suffering, ANN INT MED, 133(7), 2000, pp. 560-561
Authors:
Sulmasy, DP
Ury, WA
Ahronheim, JC
Siegler, M
Kass, L
Lantos, J
Burt, RA
Foley, K
Payne, R
Gomez, C
Krizek, TJ
Pellegrino, ED
Portenoy, RK
Citation: Dp. Sulmasy et al., Palliative treatment of last resort and assisted suicide, ANN INT MED, 133(7), 2000, pp. 562-563
Authors:
Sulmasy, DP
Ury, WA
Ahronheim, JC
Siegler, M
Kass, L
Lantos, J
Burt, RA
Foley, K
Payne, R
Gomez, C
Krizek, TJ
Pellegrino, ED
Portenoy, RK
Citation: Dp. Sulmasy et al., Publication of papers on assisted suicide and terminal sedation, ANN INT MED, 133(7), 2000, pp. 564-565
Authors:
Portenoy, RK
Citation: Rk. Portenoy, Physical symptom management in the terminally ill - An overview for mentalhealth professionals, HANDBOOK OF PSYCHIATRY IN PALLIATIVE MEDICINE, 2000, pp. 99-129